About Weave
Weave Bio is the company behind the Weave Platform, an AI-native solution built to support regulatory workflows across the therapy lifecycle. Designed for pharmaceutical companies, biotech firms, CROs, and regulatory consultants, the platform helps teams prepare and manage complex dossiers more efficiently by combining AI-powered authoring, content reuse, and streamlined responses to health authority questions.
With Weave, regulatory teams gain greater speed, consistency, and confidence in their work through an AI-driven, human-powered approach that enhances regulatory quality while reducing time and effort.
Our Investors
We partner with industry-leading experts to bring the very best technology and insights to the company
How we got here


December 2023
Seed funding from Innovation Endeavors and Magnetic Ventures

January 2024
Company launch with a focus on platform development

March 2024
Early release of AutoIND, our AI-native solution for IND preparation

June 2024
Full commercial launch of AutoIND for pharma and biotech customers

November 2024
Weave Bio Earns the 2024 “BioTech AI Innovation Of The Year” Award
